SPONSOR
Autobahn Therapeutics, Inc.
Total Trials
2
Recruiting
2
Phases
Phase 2
NCT06633016 Phase 2
Recruiting
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
Major Depressive Disorder
NCT06869187 Phase 2
Recruiting
Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults
Bipolar Disorder Depression